Ophthalmology

The Science of VKH: How It’s Found and Tracked

At a Glance

Vogt-Koyanagi-Harada (VKH) disease is diagnosed and tracked using specialized eye imaging like EDI-OCT and ICGA to detect inflammation in the choroid. Doctors may also use a lumbar puncture to find immune cells in the spinal fluid, helping confirm the disease early.

Understanding how doctors diagnose and track Vogt-Koyanagi-Harada (VKH) disease requires looking both at the microscopic level of your immune system and the advanced imaging used to see deep inside your eyes.

The Biology: An Immune System “Case of Mistaken Identity”

VKH is primarily driven by T-cells, a type of white blood cell that acts like the “generals” of your immune system ^[1]. In VKH, these T-cells—specifically a subset called Th17 cells—become overactive and mistakenly identify melanocytes (pigment-producing cells) as a threat ^[2]^[3].

Because melanocytes are found in your eyes, ears, skin, and the lining of your brain, the T-cells launch an attack in all these locations simultaneously ^[1]. This “mistaken identity” causes the body-wide inflammation characteristic of the disease.

Advanced Eye Imaging: Seeing the “Invisible”

Because the primary site of inflammation in VKH is the choroid (the layer of blood vessels deep behind the retina), standard eye exams aren’t enough. Doctors use specialized tools to see what is happening:

EDI-OCT (Enhanced Depth Imaging Optical Coherence Tomography): This is a non-invasive scan that uses light waves to take a “cross-section” of your eye ^[4]. In early VKH, it typically shows significant choroidal thickening and pockets of fluid pushing the retina up ^[5]^[6]. As you recover, doctors watch for this thickness to return to normal ^[7].
ICGA (Indocyanine Green Angiography): This test involves injecting a special dye into your arm. It is the “gold standard” for looking at the choroid ^[8]. It can reveal “dark spots” of inflammation that are invisible on other tests, helping doctors catch “silent” disease activity even when your vision seems fine ^[9]^[10].
Fluorescein Angiography (FA): Similar to ICGA but using a different dye, this helps identify leaking blood vessels and the specific patterns of fluid buildup (leakage) that are classic for VKH ^[4]^[11].

The Role of the Lumbar Puncture

During the very early “prodromal” phase, you may have undergone a lumbar puncture (spinal tap). During this procedure, a doctor carefully extracts a small amount of fluid from your lower spine. They look for CSF pleocytosis, which is an unusually high number of white blood cells in your cerebrospinal fluid ^[12]^[13]. Finding these cells helps confirm that the immune system is active in the lining of your brain, supporting a diagnosis of VKH even before eye symptoms are fully present ^[14]^[15].

How Doctors Classify VKH

Medical professionals use standardized criteria to diagnose and track VKH. Understanding the terminology in your chart can reduce confusion:

The 2001 Revised Diagnostic Criteria: You may see your disease labeled as Complete, Incomplete, or Probable VKH ^[16].

Complete: Involves the eyes, brain/ears, and skin.
Incomplete: Involves the eyes plus either the brain/ears OR the skin.
Probable: Involves the eyes alone.

The 2021 SUN Classification: More recently, experts updated the criteria to focus on standardizing the timeline of the disease ^[17]. This system links directly to the “phases” of VKH:

Early-Stage VKH: This generally covers the prodromal and acute uveitic phases, characterized by active fluid behind the retina and severe inflammation ^[17]^[18].
Late-Stage VKH: This covers the convalescent and chronic phases. It is diagnosed if you have a history of the early symptoms but now show signs of long-term pigment loss (like skin changes or a sunset glow fundus) ^[17]^[19].

Regardless of the label, the goal of treatment remains the same: to stop the T-cell attack as quickly as possible ^[20].

Common questions in this guide

Why do I need an ICGA test if my vision feels fine?

An ICGA test uses a special dye to look deep into the choroid layer of your eye. It can reveal hidden spots of inflammation that are invisible on standard tests, helping your doctor detect disease activity even when your vision seems normal.

What does an EDI-OCT scan show for VKH?

An EDI-OCT scan uses light waves to take a cross-section picture of your eye. In early VKH, it typically shows a thickened choroid and pockets of fluid pushing the retina up, which doctors use as a baseline to track your recovery.

Why would I need a spinal tap for an eye condition?

VKH affects pigment-producing cells, which are found in your eyes as well as the lining of your brain. A lumbar puncture checks your spinal fluid for an unusually high number of white blood cells, which confirms the immune system is active in your central nervous system.

What is the difference between Complete and Probable VKH?

Complete VKH involves symptoms in the eyes, brain or ears, and skin. Probable VKH means the inflammation is currently isolated to just the eyes.

What causes the body-wide inflammation in VKH?

In VKH, specific white blood cells called T-cells mistakenly identify pigment-producing cells as a threat. Because these pigment cells are located in your eyes, ears, skin, and the lining of your brain, the immune system launches an attack in all these areas simultaneously.

Curated prompts to bring to your next appointment.

1.How do my OCT scans compare between the start of my treatment and now? Is my choroidal thickness decreasing?
2.Does my indocyanine green angiography (ICGA) show 'silent' inflammation even though my vision feels better?
3.Based on the 2001 diagnostic criteria, do I have 'complete,' 'incomplete,' or 'probable' VKH?
4.What specific findings on my fluorescein angiography (FA) confirm my diagnosis?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (20)

1
Vogt-Koyanagi-Harada disease-like posterior uveitis in the course of nivolumab (anti-PD-1 antibody), interposed by vemurafenib (BRAF inhibitor), for metastatic cutaneous malignant melanoma.
Matsuo T, Yamasaki O
Clinical case reports 2017; (5(5)):694-700 doi:10.1002/ccr3.911.
PMID: 28469878
2
Increased Complement 3a Receptor is Associated with Behcet's disease and Vogt-Koyanagi-Harada disease.
Wang C, Cao S, Zhang D, et al.
Scientific reports 2017; (7(1)):15579 doi:10.1038/s41598-017-15740-8.
PMID: 29138505
3
The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy.
Huang Y, Fang S, Li D, et al.
Eye (London, England) 2019; (33(2)):176-182 doi:10.1038/s41433-018-0279-9.
PMID: 30531993
4
Common practice patterns in the diagnosis and management of Vogt-Koyanagi-Harada syndrome: a survey study of uveitis specialists.
Choo CH, Acharya NR, Shantha JG
Frontiers in ophthalmology 2023; (3()):1217711 doi:10.3389/fopht.2023.1217711.
PMID: 38983079
5
BACILLARY LAYER DETACHMENT IN ACUTE VOGT-KOYANAGI-HARADA DISEASE: A Novel Swept-Source Optical Coherence Tomography Analysis.
Agarwal A, Freund KB, Kumar A, et al.
Retina (Philadelphia, Pa.) 2021; (41(4)):774-783 doi:10.1097/IAE.0000000000002914.
PMID: 32833410
6
Vogt-Koyanagi-Harada disease.
O'Keefe GA, Rao NA
Survey of ophthalmology 2017; (62(1)):1-25 doi:10.1016/j.survophthal.2016.05.002.
PMID: 27241814
7
Evaluation of the Activity of Vogt-Koyanagi-Harada Disease; A Comparison of Indocyanine Green Angiography Scoring, Enhanced Depth Imaging Optical Coherence Tomography, and Choroidal Vascularity Index.
Fadakar K, Rezaii K, Niktinat H, et al.
Journal of current ophthalmology 2024; (36(1)):66-71 doi:10.4103/joco.joco_156_23.
PMID: 39553319
8
Vogt-Koyanagi-Harada Disease and Birdshot Retinochoroidopathy, Similarities and Differences: A Glimpse into the Clinicopathology of Stromal Choroiditis, a Perspective and a Review.
Elahi S, Herbort CP
Klinische Monatsblatter fur Augenheilkunde 2019; (236(4)):492-510 doi:10.1055/a-0829-6763.
PMID: 30891715
9
Vogt-Koyanagi-Harada disease is always bilateral: reports of unilateral cases failed to use choroidal investigations showing subclinical involvement of the fellow eye.
Papasavvas I, Herbort CP
Journal of ophthalmic inflammation and infection 2021; (11(1)):6 doi:10.1186/s12348-021-00237-3.
PMID: 33559795
10
Choroidal circulation impairment during the anterior recurrence of Vogt-Koyanagi-Harada disease confirmed with indocyanine green angiography and laser speckle flowgraphy.
Takemoto Y, Namba K, Mizuuchi K, et al.
Acta ophthalmologica 2016; (94(7)):e629-e636 doi:10.1111/aos.13024.
PMID: 27079805
11
[Autofluorescence combined with spectral domain optical coherence tomography for diagnosis and follow-up of acute Vogt-Koyanagi-Harada disease].
Tian S, Yao J, Wang J, et al.
Nan fang yi ke da xue xue bao = Journal of Southern Medical University 2021; (41(1)):135-140 doi:10.12122/j.issn.1673-4254.2021.01.20.
PMID: 33509766
12
[A rare case of ocular scarrings in a patient with Vogt-Koyanagi-Harada disease].
Belmokhtar A, Daoudi R
The Pan African medical journal 2017; (28()):313 doi:10.11604/pamj.2017.28.313.4547.
PMID: 29721143
13
Vogt-Koyanagi-Harada disease in a patient with retinitis pigmentosa in one eye and pigmented paravenous retinochoroidal atrophy in the other eye.
Sato J, Hashizume K, Nishida Y, et al.
American journal of ophthalmology case reports 2025; (38()):102298 doi:10.1016/j.ajoc.2025.102298.
PMID: 40144311
14
Vogt-Koyanagi-Harada Disease, a Rare Entity in Spain: The Challenge of Worldwide Immigration and Globalization.
Fernández AB, Moyano SP, Husein-ElAhmed H, Juárez AMA
European journal of case reports in internal medicine 2018; (5(7)):000886 doi:10.12890/2018_000886.
PMID: 30756049
15
Vogt-Koyanagi-Harada disease.
Street D, Sivaguru A, Sreekantam S, Mollan SP
Practical neurology 2019; (19(4)):364-367 doi:10.1136/practneurol-2018-002152.
PMID: 30890584
16
Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
Vukojević M, Vukojevic N, Vuković A, et al.
Acta dermatovenerologica Croatica : ADC 2023; (31(4)):229-231.
PMID: 38651852
17
Classification Criteria for Vogt-Koyanagi-Harada Disease.

American journal of ophthalmology 2021; (228()):205-211 doi:10.1016/j.ajo.2021.03.036.
PMID: 33845018
18
Vogt-Koyanagi-Harada disease.
Joye A, Suhler E
Current opinion in ophthalmology 2021; (32(6)):574-582 doi:10.1097/ICU.0000000000000809.
PMID: 34545845
19
Melanin change of retinal pigment epithelium and choroid in the convalescent stage of Vogt-Koyanagi-Harada disease.
Huang Y, Yang YT, Lin B, et al.
International journal of ophthalmology 2020; (13(12)):1928-1932 doi:10.18240/ijo.2020.12.13.
PMID: 33344192
20
Predictive Factors for Uveitis Refractory to Treatment in Initial-Onset Acute Vogt-Koyanagi-Harada Disease.
Gin TJ, Surendran SA, Rogers SL, Lim LL
Clinical & experimental ophthalmology 2025; (53(6)):627-636 doi:10.1111/ceo.14538.
PMID: 40254294

This page explains VKH diagnostic tests and classifications for educational purposes only. Always consult your ophthalmologist or specialist to interpret your specific imaging results and medical charts.

Get notified when new evidence is published on Vogt-Koyanagi-Harada disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents